MOVES-Deutsche Bank head of restructuring finance joins RBC -sources
March 23 Mark Cohen, the head of restructuring finance at Deutsche Bank AG, will join Royal Bank of Canada as head of its U.S. capital solutions group in New York in June, people familiar with the matter said on Thursday.
See the original post here:
BRIEF-Atossa Genetics files for public offering of up to 4 mln units - Reuters
Toward the end of trading Thursday, the Dow traded up 0.29 percent to 20,721.07 while the NASDAQ rose 0.17 percent to 5,831.32. The S&P also rose, gaining 0.22 percent to 2,353.52.
Leading and Lagging Sectors
Thursday afternoon, the financial sector proved to be a source of strength for the market. Leading the sector was strength from New England Realty Associates LP (NYSE: NEN) and Ladenburg Thalmann Financial Services (NYSE: LTS).
In trading on Thursday, telecommunications services shares fell 0.12 percent. Meanwhile, top losers in the sector included China Mobile Ltd. (ADR) (NYSE: CHL), down 3 percent, and Partner Communications Company Ltd (ADR) (NASDAQ: PTNR), down 1.5 percent.
Top Headline
Conagra Brands Inc (NYSE: CAG) reported stronger-than-expected earnings for its third quarter.
Conagra reported Q3 earnings of $0.48 per share on revenue of $1.98 billion. Analysts were expecting earnings of $0.44 per share on revenue of $1.98 billion.
Equities Trading UP
HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares shot up 106 percent to $4.40 after the molecular profiling company confirmed regulatory approval for its products in Europe. HTG Molecular announced that it has obtained CE marking in the European Union for its HTG EdgeSeqALKPlus Assay EU, an in vitro diagnostic assay which is intended to measure and analyze mRNA ALK gene rearrangements in formalin-fixed, paraffin-embedded lung tumor specimens from patients previously diagnosed with non-small cell lung cancer.
Shares of Cancer Genetics Inc (NASDAQ: CGIX) got a boost, shooting up 17 percent to $3.39 after the company posted a narrower-than-expected quarterly loss.
Flexion Therapeutics Inc (NASDAQ: FLXN) shares were also up, gaining 36 percent to $26.75. Fierce Pharma reported that Sanofi is on verge of $1 billion-plus deal for Flexion, according to sources.
Equities Trading DOWN
Tandem Diabetes Care Inc (NASDAQ: TNDM) shares dropped 19 percent to $1.25. Tandem Diabetes Care priced its 18 million share offering at $1.25 per share.
Shares of Alphatec Holdings Inc (NASDAQ: ATEC) were down around 25 percent to $2.00 as the company reported an $18.9 million private placement.
Heat Biologics Inc (NASDAQ: HTBX) was down, falling around 15 percent to $0.872. Heat Biologics priced its 5 million share offering at $0.80 per share.
Commodities
In commodity news, oil traded down 0.54 percent to $47.78 while gold traded down 0.31 percent to $1,248.90.
Silver traded up 0.18 percent Thursday to $17.61, while copper rose 0.82 percent to $2.65.
Eurozone
European shares closed higher today. The eurozones STOXX 600 rose 0.85 percent, the Spanish Ibex Index rose 0.93 percent, while Italys FTSE MIB Index rose 1.07 percent. Meanwhile the German DAX gained 1.14 percent, and the French CAC 40 rose 0.75 percent while U.K. shares rose 0.22 percent.
Economics
Initial jobless claims rose 15,000 to 258,000 in the latest week. Economists projected jobless claims to reach 240,000 in the week.
New-home sales rose 6.1 percent to an annual rate of 592,000 in February. Economists were expecting a 571,000 annual pace.
Supplies of natural gas dropped 150 billion cubic feet for the week ended March 17, the U.S. Energy Information Administration reported. Analysts projected a fall of 153 billion cubic feet.
Data on money supply for the recent week will be released at 4:30 p.m. ET.
Dallas Federal Reserve Bank President Robert Kaplan will speak in Chicago at 7:00 p.m. ET.
Posted-In: Earnings News Eurozone Commodities Offerings Global Intraday Update Markets
2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Read the original here:
Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide - Benzinga
NEW YORK (GenomeWeb) Cancer Genetics reported today that its fourth quarter revenues grew 32 percent year over year.
For the three months ended Dec. 31, 2016, the company reported revenues of $7.2 million up from $5.5 million in Q4 2015.
Registering provides access to this and other free content.
Already have an account? .
Read this article:
Cancer Genetics Q4 Revenues Up 32 Percent - GenomeWeb
Dr. Asuncion Fernandes, St. Lukes Medical Centre, Quezon City, PhilippinesDr. Mike Macnamee, MSc, PhD, Chief Executive, Bourn Hall Clinic, Cambridge, UK Lets Do ICSI 03rd - 07th Dec 2007 Shabaan AI-Dahha, HOD Basra Medical College, Basra, Iraq - Lets Do ART, Special Bath 18th Feb - 01st March 2008Dr. Dandapani Banerjee, Kolkata, India Dr. Alka Sen, Sen Maternity & Eye Hospital (P) Ltd, Agra, IndiaDr. Asheesh Gude, Sinai Fertility Center, Margo, Goa, India. Dr. Sanjukta Saha, Moulana Bhasani Medical College, Dhaka, Bangladesh Dr. Faiz Alwaeely, Asst Professor, Basra Medical College, Basra, IraqDr. Shamima Dawood, Linmed Hospital, Johanesburg, South AfricaA moment of Pride - Bourn Hall Clinic Team with the traineesDr. Sabina Shreshta, Om Hospital, Katmandu, NepalBackground-Dr. Earnest J. Moloi, Medi Clinic, Welkom, South Africa Foreground-Dr. Mohammad Ahmad Maarouf, RomaniaDr. Lucy Coleman, Whiltshire, UK Dr. Sanjay Gandhi,City Gem IVF, Dessa, Gujarat. India.
More here:
Embryology Academy for Research Training
The earliest mutations of human life have been observed by researchers at the Wellcome Trust Sanger Institute and their collaborators. Analysing genomes from adult cells, the scientists could look back in time to reveal how each embryo developed.
Published in Nature, the study shows that from the two-cell stage of the human embryo, one of these cells becomes more dominant than the other and leads to a higher proportion of the adult body.
A longstanding question for researchers has been what happens in the very early human development as this has proved impossible to study directly. Now, researchers have analyzed the whole genome sequences of blood samples (collected from 279 individuals with breast cancer) and discovered 163 mutations that occurred very early in the embryonic development of those people.
Once identified, the researchers used mutations from the first, second and third divisions of the fertilized egg to calculate which proportion of adult cells resulted from each of the first two cells in the embryo. They found that these first two cells contribute differently to the whole body. One cell gives rise to about 70 percent of the adult body tissues, whereas the other cell has a more minor contribution, leading to about 30 percent of the tissues. This skewed contribution continues for some cells in the second and third generation too.
Originally pinpointed in normal blood cells from cancer patients, the researchers then looked for these mutations in cancer samples that had been surgically removed from the patients during treatment. Unlike normal tissues composed of multiple somatic cell clones, a cancer develops from one mutant cell. Therefore, each proposed embryonic mutation should either be present in all of the cancer cells in a tumor, or none of them. This proved to be the case, and by using these cancer samples, the researchers were able to validate that the mutations had originated during early development.
"This is the first time that anyone has seen where mutations arise in the very early human development. It is like finding a needle in a haystack. There are just a handful of these mutations, compared with millions of inherited genetic variations, and finding them allowed us to track what happened during embryogenesis," said Young Seok Ju, first author from the Wellcome Trust Sanger Institute and the Korea Advanced Institute of Science and Technology (KAIST).
"Having identified the mutations, we were able to use statistical analysis to better understand cell dynamics during embryo development. We determined the relative contribution of the first embryonic cells to the adult blood cell pool and found one dominant cell - that led to 70 percent of the blood cells - and one minor cell. We also sequenced normal lymph and breast cells, and the results suggested that the dominant cell also contributes to these other tissues at a similar level. This opens an unprecedented window into the earliest stages of human development," said Inigo Martincorena, from the Sanger Institute.
During this study, the researchers were also able to measure the rate of mutation in early human development for the first time, up to three generations of cell division. Previous researchers had estimated one mutation per cell division, but this study measured three mutations for each cell doubling, in every daughter cell.
Mutations during the development of the embryo occur by two processes - known as mutational signatures 1 and 5. These mutations are fairly randomly distributed through the genome, and the vast majority of them will not affect the developing embryo. However, a mutation that occurs in an important gene can lead to disease such as developmental disorders.
"This is a significant step forward in widening the range of biological insights that can be extracted using genome sequences and mutations. Essentially, the mutations are archaeological traces of embryonic development left in our adult tissues, so if we can find and interpret them, we can understand human embryology better. This is just one early insight into human development, with hopefully many more to come in the future," said Mike Stratton, lead author on the paper and director of the Sanger Institute.
See the original post here:
First Mutations in Human Life Discovered - Laboratory Equipment - Laboratory Equipment
The report Global Biochemistry Analyzers Market 2017 is a professional, in-depth study that includes insights extracted from complex information, which clients can use for their business advantage. A large volume of precise, reliable market data has been distilled into clear and actionable insight for clients so that they can formulate their plans or make crucial business decisions with precision.
The report begins with an overview of the Biochemistry Analyzers market and defines the trends that have shaped the global Biochemistry Analyzers market. The key market drivers, restraints, and opportunities that will shape the dynamics of the Biochemistry Analyzers market have been presented in the report. A detailed analysis of the key challenges the players in the market face has been also covered in the report. Key inputs from leading industry experts mentioned in the report address how these challenges can be turned into opportunities.
Request for Sample Report @http://www.9dresearchgroup.com/report/113962/request-sample
A detailed segmentation analysis of the Biochemistry Analyzers market is available in the report. The key segments in the Biochemistry Analyzers industry along with their sub-segments have been covered in the report. The performance analysis of these segments and sub-segments has been included in the report along with detailed evaluation of the trends that will influence the growth prospects of these segments. Moreover, niche segments that demonstrate good growth potential and thus opportunities for new entrants and established companies in the market have been covered.
Market forecasts and estimates for each key segment and its sub-segments are available in the report. All estimates and forecasts in the Biochemistry Analyzers market study have been verified by the exhaustive primary research with the KIPs (key industry participants), which include the markets leading participants, key consumers and clients, and client distributors and vendors. A detailed company-wise analysis of the leading market players has also been covered in the Biochemistry Analyzers market report.
Inquiry for Buying Report @http://www.9dresearchgroup.com/report/113962/inquiry-for-buying
Analysis also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals. In the end, the report includes Biochemistry Analyzers new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis. In conclusion, it is a deep research report on Global Biochemistry Analyzers industry. Here, we express our thanks for the support and assistance from Biochemistry Analyzers industry chain related technical experts and marketing engineers during Research Teams survey and interviews.
Read more here:
Global Biochemistry Analyzers Market Forecast Research Report 2017 2021 - GreaterPatchogueDaily
A censored 16th century anatomy book may provide evidence that taboos slowed the development of knowledge of the female genitals, researchers have said.
The 1559 edition of Thomas Gemini's Compediosa Totius Anatomie Delineatio features a depiction of a semi-dissected female torso, and the book's original owner has cut away a neat triangle of paper on which the vagina would have been drawn.
It will be displayed in an exhibition at St John's College at the University of Cambridge, and curator Shelley Hughes said it may offer clues as to why knowledge of the female anatomy lagged behind that of the human body as a whole.
She said the book's original owner was disturbed by its depiction of a semi-dissected female torso.We know this because the offending part, a neat triangle of paper on which the vagina would have been drawn, has been carefully cut away.
She added: Sin and female flesh were held in close association in 16th century society with naked women often portrayed as the servants of Satan.Perhaps Christian Europe would have to overcome its shame over the female reproductive organs in order to discover more about their structure.
Before the 16th century, many European academics believed that female genital organs were simply lesser versions of male organs, turned inside out.
This dated back to classical medical authorities such as Galen in the 2nd century, who had been prohibited by law in Ancient Rome from cutting up human corpses.
The 16th century was a time of medical revolution, with pioneering researchers such as Andreas Vesalius challenging accepted views on anatomy, with evidence gathered from human dissections and direct observation experiment.
But there was still a reluctance to take on some foundational beliefs in science.
The display shows how an evidence-based knowledge of the structure of the body emerged as superstitious and religious barriers weakened.
The exhibition, to be displayed on Saturday, is called Under The Knife At St John's: A Medical History Of Disease And Dissection
See more here:
Censored 16th century anatomy textbook could be root of vagina taboo - The Independent
Poor Maggie Piercehas no idea what she's about to be hit with.
With Grey's Anatomy returning to Grey Sloan Memorial after last week's sojourn to Montana for a little Japril action, the focus will turn to the young cardiothoracic doc thanks to a return visit from her mom Diane (LaTanya Richardson Jackson), who's back to treat the breast cancer she's still hiding from her daughter. Oh, and there's the small matter of that growing attraction between Meredith (Ellen Pompeo) and the object of Maggie's affection, Riggs (Martin Henderson), finally coming to the forefront.
E! News caught up with Kelly McCreary on the red carpet at the long-running ABC series' PaleyFest event, where she gave us some insight into how the surgeon will handle her world basically falling apart at the seams.
ABC
"I think, first and foremost, Maggie is the brightest person she knows," McCreary told us about the urgent matter to save her mom's life. "And she's going to try to solve her problems herself. And of course, when you try to do everything yourself, you get tuckered out." We've got a feeling that Jackson (Jesse Williams), Diane's chosen doctor and the reason she came to Seattle for treatment, is going to have something to say about that.
And as for the small matter of her half-sister taking up with her crush?"It's a bad idea to keep secrets. Just don't do it," she joked. "I don't think the audience is going to get the reaction that they're expecting out of Maggie. Let's put it that way."
Elsewhere in the episode, Owen (Kevin McKidd) and Amelia (Caterina Scorsone) finally hash out their problems as they work a trauma case together, while Bailey (Chandra Wilson) tries to mend her relationship with Richard (James Pickens Jr.) after, you know, stabbing him in the back and taking the Residency program away from him. Good luck with that, Bailey!
For more from McCreary, be sure to check out the video above.
What sort of unexpected reaction do you think Maggie will have to the Mer-Riggs relationship? Share your theories in the comments below!
Grey's Anatomy airs Thursdays at 8 p.m. on ABC.
E! Online - Your source for entertainment news, celebrities, celeb news, and celebrity gossip. Check out the hottest fashion, photos, movies and TV shows!
See more here:
Grey's Anatomy's Kelly McCreary Teases Maggie's Double Dose of Drama Ahead - E! Online
We love Shonda Rhimes. As far as we're concerned, every year is a Year of Yes. But when a star of not one but two of the prolific showrunner's series decides to willingly spill some tea about Shonda, of course we're going to be all ears.
That's exactly what Grey's Anatomy and Private Practice star Kate Walsh did when she appeared on Watch What Happens Live with Andy Cohen Wednesday night as she answered questions posed by the Shady Shonda Anaconda who slithered onto the screen.
Though Shonda is legendary for her gift giving, not every present has been a winner. "We once got, I think, just a box of potpourri," Kate said on WWHL. "We were like, 'Really? We just won every award known to man. That's cool. That's super cool.'"
Kate also revealed that she thought Grey's Anatomy jumped the shark during "the bomb episode," the Season 2 episode entitled "As We Know It." "But that's the one that made it everything, that made Grey's Anatomy," Kate explained. "I'd say she jumped that shark, but then we rode it all the way to the top."
So did Shonda ever throw any shade of her own? "Here's what I will say, we had on Private Practice, all I'll say is there was a no a-hole policy," Kate replied. "How about that?"
We guess we'll take it.
Watch Kate and her fellow WWHL guest Laura Dern spill some more Hollywood secrets, below.
Original post:
Kate Walsh Let the Shade Fly About Shonda Rhimes and Grey's Anatomy - Bravo (blog)
Playing Ellen Pompeo on Her Greys Anatomy Directorial Debut and Hiring a Baby Nurse: Id Be Nowhere Without Her
Ellen Pompeo is dishing on the secret to juggling motherhood with a busy career, which comes to a head with her upcoming Greys Anatomy directorial debut -- nurse Jackie!
The 47-year-old mom-of-three stopped by The Ellen DeGeneres Show, where her 5-month-old son, Eli, waited backstage.
WATCH: Ellen Pompeo Shares Boy Crazy Video Dancing With Infant Son
He is the sweetest thing ever so adorable, Pompeo gushed, before adding that the tot is now sleeping through the night. He is. I have the most fantastic baby nurse, Jackie, whos also backstage -- Hi Jackie!
She helps me and Id be nowhere without her because I work long days and I need help caring for him, she continued. Shes got my back -- and his. Its funny because everyone who meets her is like, I want Jackie! and Im like, You dont have a baby. [Theyre like], Yeah, I know but I just want Jackie!
Photo: Michael Rozman/Warner Bros
Long days at work are nothing new for the Greys veteran, but shes been even busier than usual on set lately, due to directing her first episode of the ABC series.
Titled Be Still, My Soul, the episode airs on March 30, and Pompeo said she had a blast behind the camera.
I definitely had an advantage being there for 13 seasons, says Pompeo, whose Ellen appearance airs on March 23. It was super fun. [Executive producer] Debbie Allen really wasnt going to take no for an answer and enough women dont get the opportunity to direct, so I thought, Who am I to get the opportunity and say no?
EXCLUSIVE: Greys Anatomy Star Justin Chambers on a Meredith-Alex Romance
If work and kids arent enough to keep her busy, Pompeo also added to the familys brood by adopting another dog recently.
[I now have] four dogs, four chickens and a fish, she shared. Oh, and a husband too.
We adopted Lily from Love Leo Rescue, she said of the new addition. I was scared for her when she first came because she was scared. Every time someone would come in the house she would run and hide under a bed. Ive worked with her a lot to get her to the place where she is comfortable and she has made the most amazing progress. Shes a completely different dog.
See what Pompeos castmate, Justin Chambers, had to say about a possible Alex-Meredith romance on the show in the video below.
Read the original:
Ellen Pompeo on Her 'Grey's Anatomy' Directorial Debut and Hiring a Baby Nurse: 'I'd Be Nowhere Without Her' - Entertainment Tonight